Clinical Trials Directory

Trials / Completed

CompletedNCT07473557

Clinical Outcomes of the Use of a Femtosecond Laser on an Implanted Intraocular Lens

A Prospective Study to Assess the Clinical and Refractive Outcomes of the Use of a Femtosecond Laser on an Implanted Intraocular Lens

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Perfect Lens, LLC · Industry
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is a prospective non-randomized patient controlled single center study which is designed to evaluate the clinical outcomes of the treatment of an implanted intraocular lens using a low-energy femtosecond laser for refractive correction.

Detailed description

The purpose of this research study is to evaluate the safety and efficacy of the treatment of an implanted intraocular lens with a device. The device employs a generic femtosecond laser used in numerous other ophthalmic procedures. The device uses low levels of energy from the femtosecond laser to correct spherical, cylindrical and sphero-cylindrical refractive error existing in an implanted intraocular lens. The refractive correction is effected through the treatment, which is employed at least 30 days after cataract surgery.

Conditions

Interventions

TypeNameDescription
OTHERDeviceThe Perfector is used in the procedure. The device is attached to the patient by the use of a patient attachment. The patient attachment attaches to the sclera of the eye using vacuum pressure.

Timeline

Start date
2019-01-18
Primary completion
2022-09-16
Completion
2022-09-16
First posted
2026-03-16
Last updated
2026-03-19

Locations

1 site across 1 country: Panama

Source: ClinicalTrials.gov record NCT07473557. Inclusion in this directory is not an endorsement.